Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Comments

Response to Comment on: “Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications”

New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY, USA; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY, USA; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Immuno-Oncology Program, Memorial Sloan Kettering Cancer Center, New York, NY
Haematologica Early view Oct 15, 2026 https://doi.org/10.3324/haematol.2026.302137

Abstract

Not available.

Figures & Tables

Article Information

Early view : Comments
 
DOI
https://doi.org/10.3324/haematol.2026.302137
Pubmed
42876288
 
Published
2026-10-15
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
45
PDF Downloads
46
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online